Cell and gene therapies
-
NZ ups its game in CAR-T
- 16 Aug 2023
Collaboration with Malaghan and BioOra looks to ‘take CAR-T to the people’ with new manufacturing process.
Read more -
CAR-T the ‘gold standard’ for cancer
- 26 Jul 2023
Peter Mac Director Professor Simon Harrison says Australia now has excess capacity in cell therapies – and now it needs the products.
Read more -
US threat to Aussie biotech sector
- 21 Jul 2023
Productivity Commission warns of an international threat to Melbourne’s biotech cluster as the local industry body calls for greater investment.
Read more -
Australia lags in cell and gene access
- 09 Jun 2023
Two years after a landmark report was launched, a review finds little progress has been made.
Read more -
Lost year in TGA therapy review
- 09 Jun 2023
After 278 days went missing in the TGA evaluation of a potentially game-changing therapy, we look at what caused the delay.
Read more -
Newest TGA fast track up and running
- 07 Jun 2023
A recommendation of the Zimmerman Report, cell and gene therapies now have a potentially faster path to the Australian market.
Read more -
Genetics trumps stats in Folbigg case
- 07 Jun 2023
Leading Australian scientists say genetics has unlocked the key to the mystery of Kathleen Folbigg’s children dying, leading to her freedom.
Read more -
HTA not fit for purpose: Butler
- 30 May 2023
Health Minister says ‘turbocharged period of discovery’ is overwhelming the current system, and patients are dying.
Read more